Related Experiment Video
Updated: May 12, 2026
05:39
Spontaneous Murine Model of Anaplastic Thyroid Cancer
Published on: February 3, 2023
Anaplastic thyroid cancer
James Paul O'Neill1, Ashok R Shaha
1Otolaryngology, Head and Neck Surgery, The Royal College of Surgeons in Ireland, 123 St. Stephens Green, Dublin, Ireland. joneill@rcsi.ie
Oral Oncology
|April 16, 2013
Summary
Anaplastic thyroid cancer (ATC) is aggressive, with poor survival rates. Multidisciplinary strategies, guided by American Thyroid Association (ATA) guidelines, are crucial for optimizing patient management and improving outcomes.
Area of Science:
- Oncology
- Endocrinology
Background:
- Anaplastic thyroid cancer (ATC) is a highly lethal thyroid malignancy.
- ATC accounts for a disproportionate number of thyroid cancer deaths globally.
- The American Thyroid Association (ATA) has issued new guidelines for ATC management.
Purpose of the Study:
- To review the recent ATA guidelines for anaplastic thyroid cancer.
- To discuss multidisciplinary strategies for optimizing ATC patient management.
Main Methods:
- Review of the latest ATA guideline publication.
- Systematic literature review of ATC studies via Medline and Pubmed.
Main Results:
- ATC patients have a median survival of 5 months; <20% survive 1 year.
- High rates of early tumor dissemination (20-50% distant metastases, 90% local invasion).
- Multimodal therapy (surgery, IMRT, systemic therapy) may benefit resectable Stage IVA/IVB disease.
Conclusions:
- Effective ATC management requires rapid, integrated, multidisciplinary decision-making.
- Early palliative care and life-prolonging therapies are essential.
- Adherence to ATA guidelines is key for optimizing ATC patient care.
Related Concept Videos
01:27Hyperthyroidism II: Pathophysiology
Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
01:24Graves Disease II: Pathophysiology
Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
01:25Hyperthyroidism I: Introduction
Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
01:28Graves' Disease I: Introduction
Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:23The Thyroid Gland
The thyroid gland is a small, butterfly-shaped gland located in the neck and covers the anterior surface of the trachea. The gland has two lateral lobes connected by a thin tissue mass called the isthmus. Internally, each lobe comprises many small spherical structures known as thyroid follicles, surrounded by a network of blood vessels.
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...
The follicles have a central cavity lined by simple cuboidal to squamous epithelial cells called follicular cells. These cells produce the glycoprotein...